| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | delayed brain development | 9.56e-05 | 11 | 19 | 2 | MP:0001889 | |
| MousePheno | irregular heartbeat | 1.15e-04 | 71 | 19 | 3 | MP:0001636 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.37e-04 | 1269 | 19 | 8 | MP:0011111 | |
| MousePheno | decreased hepatocyte number | 1.82e-04 | 15 | 19 | 2 | MP:0000606 | |
| MousePheno | thin myocardium | 1.96e-04 | 85 | 19 | 3 | MP:0002652 | |
| MousePheno | lethality throughout fetal growth and development | 2.31e-04 | 435 | 19 | 5 | MP:0006208 | |
| Domain | Ion_trans_dom | 7.19e-03 | 114 | 21 | 2 | IPR005821 | |
| Domain | Ion_trans | 7.19e-03 | 114 | 21 | 2 | PF00520 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 28591638 | ||
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 36354136 | ||
| Pubmed | 1.36e-05 | 1429 | 21 | 7 | 35140242 | ||
| Pubmed | 1.73e-05 | 263 | 21 | 4 | 34702444 | ||
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.94e-05 | 271 | 21 | 4 | 25737280 | |
| Pubmed | 2.26e-05 | 591 | 21 | 5 | 15231748 | ||
| Pubmed | 2.73e-05 | 1049 | 21 | 6 | 27880917 | ||
| Pubmed | 4.66e-05 | 339 | 21 | 4 | 30415952 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.33e-05 | 351 | 21 | 4 | 38297188 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.48e-05 | 123 | 21 | 3 | 26912792 | |
| Pubmed | 6.55e-05 | 20 | 21 | 2 | 35177643 | ||
| Pubmed | Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development. | 7.24e-05 | 21 | 21 | 2 | 31680852 | |
| Pubmed | 1.05e-04 | 418 | 21 | 4 | 34709266 | ||
| Pubmed | 1.11e-04 | 156 | 21 | 3 | 37108203 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.17e-04 | 430 | 21 | 4 | 35044719 | |
| Pubmed | 1.30e-04 | 28 | 21 | 2 | 29365100 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 1.67e-04 | 1455 | 21 | 6 | 22863883 | |
| Pubmed | Single-cell transcriptomic analysis reveals diversity within mammalian spinal motor neurons. | 1.70e-04 | 32 | 21 | 2 | 36596814 | |
| Pubmed | 1.87e-04 | 486 | 21 | 4 | 20936779 | ||
| Pubmed | 1.95e-04 | 189 | 21 | 3 | 31594818 | ||
| Pubmed | 2.13e-04 | 503 | 21 | 4 | 16964243 | ||
| Pubmed | 2.18e-04 | 506 | 21 | 4 | 30890647 | ||
| Pubmed | 2.70e-04 | 211 | 21 | 3 | 7566098 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.31e-04 | 565 | 21 | 4 | 25468996 | |
| Pubmed | 4.23e-04 | 1103 | 21 | 5 | 34189442 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.27e-04 | 1105 | 21 | 5 | 35748872 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 4.28e-04 | 247 | 21 | 3 | 32989298 | |
| Pubmed | 4.44e-04 | 250 | 21 | 3 | 33536335 | ||
| Pubmed | 5.43e-04 | 268 | 21 | 3 | 33640491 | ||
| Interaction | ERG interactions | 2.15e-06 | 223 | 20 | 5 | int:ERG | |
| Interaction | SP7 interactions | 9.73e-06 | 304 | 20 | 5 | int:SP7 | |
| Interaction | IPO11 interactions | 1.64e-05 | 159 | 20 | 4 | int:IPO11 | |
| Interaction | VSX1 interactions | 3.68e-05 | 66 | 20 | 3 | int:VSX1 | |
| Interaction | PHIP interactions | 3.80e-05 | 197 | 20 | 4 | int:PHIP | |
| Interaction | FEV interactions | 4.27e-05 | 203 | 20 | 4 | int:FEV | |
| Interaction | B9D2 interactions | 4.97e-05 | 73 | 20 | 3 | int:B9D2 | |
| Interaction | NFIX interactions | 6.59e-05 | 227 | 20 | 4 | int:NFIX | |
| Interaction | TAF1 interactions | 1.11e-04 | 260 | 20 | 4 | int:TAF1 | |
| Interaction | GTF2A1 interactions | 1.43e-04 | 104 | 20 | 3 | int:GTF2A1 | |
| Interaction | TSC22D1 interactions | 1.43e-04 | 104 | 20 | 3 | int:TSC22D1 | |
| Interaction | TBXT interactions | 1.97e-04 | 116 | 20 | 3 | int:TBXT | |
| Interaction | ELK3 interactions | 2.18e-04 | 120 | 20 | 3 | int:ELK3 | |
| Interaction | PAX9 interactions | 2.76e-04 | 130 | 20 | 3 | int:PAX9 | |
| Interaction | CCNK interactions | 2.89e-04 | 132 | 20 | 3 | int:CCNK | |
| Interaction | PMCH interactions | 3.00e-04 | 26 | 20 | 2 | int:PMCH | |
| Interaction | NEK3 interactions | 3.00e-04 | 26 | 20 | 2 | int:NEK3 | |
| Interaction | NR2F2 interactions | 3.36e-04 | 139 | 20 | 3 | int:NR2F2 | |
| Interaction | TOP3B interactions | 3.60e-04 | 1470 | 20 | 7 | int:TOP3B | |
| Interaction | ZNF148 interactions | 3.73e-04 | 144 | 20 | 3 | int:ZNF148 | |
| Interaction | MYH10 interactions | 3.83e-04 | 359 | 20 | 4 | int:MYH10 | |
| Interaction | PAX6 interactions | 4.12e-04 | 366 | 20 | 4 | int:PAX6 | |
| Interaction | GCG interactions | 4.28e-04 | 31 | 20 | 2 | int:GCG | |
| Interaction | CCDC22 interactions | 4.36e-04 | 152 | 20 | 3 | int:CCDC22 | |
| Interaction | ENOX2 interactions | 4.56e-04 | 32 | 20 | 2 | int:ENOX2 | |
| Interaction | SLFN11 interactions | 4.56e-04 | 376 | 20 | 4 | int:SLFN11 | |
| Interaction | ACTC1 interactions | 4.81e-04 | 694 | 20 | 5 | int:ACTC1 | |
| Interaction | AURKA interactions | 4.87e-04 | 696 | 20 | 5 | int:AURKA | |
| Interaction | CNTNAP2 interactions | 4.89e-04 | 158 | 20 | 3 | int:CNTNAP2 | |
| Interaction | SOX5 interactions | 5.26e-04 | 162 | 20 | 3 | int:SOX5 | |
| Interaction | SPSB3 interactions | 6.10e-04 | 37 | 20 | 2 | int:SPSB3 | |
| Interaction | EGR2 interactions | 6.15e-04 | 171 | 20 | 3 | int:EGR2 | |
| Interaction | UNK interactions | 6.20e-04 | 408 | 20 | 4 | int:UNK | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-06 | 180 | 21 | 4 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.90e-05 | 153 | 21 | 3 | 7518187a5fbf6c0881182dc79bd37c2d49f92b2e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.90e-05 | 153 | 21 | 3 | 93d36723f01c2df39feebf20f3eba5b4fb4cdf59 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.50e-05 | 159 | 21 | 3 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.60e-05 | 160 | 21 | 3 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 173 | 21 | 3 | e3cb7c8c09f937da6b8d673e9adfec5d94a15548 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.31e-05 | 175 | 21 | 3 | 5f5fc1bf29f07e086951d4f9486b5f07bdcc5d4f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.56e-05 | 177 | 21 | 3 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 199 | 21 | 3 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 199 | 21 | 3 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| Disease | non-melanoma skin carcinoma | 3.37e-05 | 265 | 21 | 4 | EFO_0009260 | |
| Disease | actinic keratosis | 4.37e-05 | 14 | 21 | 2 | EFO_0002496 | |
| Disease | puberty onset measurement | 9.33e-05 | 125 | 21 | 3 | EFO_0005677 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 5.46e-04 | 228 | 21 | 3 | EFO_0003948, MONDO_0004975 | |
| Disease | squamous cell carcinoma | 1.04e-03 | 67 | 21 | 2 | EFO_0000707 | |
| Disease | synophrys measurement | 1.07e-03 | 68 | 21 | 2 | EFO_0007906 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.07e-03 | 68 | 21 | 2 | EFO_0007826, EFO_0007860 | |
| Disease | age at menopause | 1.23e-03 | 302 | 21 | 3 | EFO_0004704 | |
| Disease | Autism Spectrum Disorders | 1.66e-03 | 85 | 21 | 2 | C1510586 | |
| Disease | subcutaneous adipose tissue measurement | 1.98e-03 | 93 | 21 | 2 | EFO_0004766 | |
| Disease | Neurodevelopmental Disorders | 1.98e-03 | 93 | 21 | 2 | C1535926 | |
| Disease | sleep duration | 2.07e-03 | 362 | 21 | 3 | EFO_0005271 | |
| Disease | mean fractional anisotropy measurement | 2.07e-03 | 95 | 21 | 2 | EFO_0008399 | |
| Disease | corpus callosum volume measurement | 2.29e-03 | 100 | 21 | 2 | EFO_0010299 | |
| Disease | Vitiligo | 2.33e-03 | 101 | 21 | 2 | EFO_0004208 | |
| Disease | suntan | 2.43e-03 | 103 | 21 | 2 | EFO_0004279 | |
| Disease | Epilepsy | 2.71e-03 | 109 | 21 | 2 | C0014544 | |
| Disease | keratinocyte carcinoma | 3.17e-03 | 118 | 21 | 2 | EFO_0010176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLDNLLSPLQPQLPM | 2141 | Q9NR09 | |
| QPPLLLPLLQPQLLQ | 36 | Q14004 | |
| LGNILLNVLIPPNMP | 401 | Q9UKX7 | |
| IQLIAMQPIPAPPVQ | 1486 | Q9HCM3 | |
| QPQQRLIMPATPLPQ | 431 | Q6MZP7 | |
| LIMPATPLPQIQPNL | 436 | Q6MZP7 | |
| MPLPAGLPNLPNLNL | 306 | Q9H8Y8 | |
| PEGPQPPMILLQQLL | 2371 | O95714 | |
| MITIPPSILNNPNIP | 176 | P52272 | |
| QMPLQVPPQIPCQDI | 956 | Q8NCM2 | |
| QPALPLQPLAQGMIP | 211 | Q9H334 | |
| MPPCQPQRPLLLLLL | 1 | P47871 | |
| QPVEQRPLQQMPPQL | 976 | Q14686 | |
| LPLPLLQPLMQQVPQ | 141 | P05814 | |
| LQPLMQQVPQPIPQT | 146 | P05814 | |
| PLQIQQIPIPKLAAP | 306 | Q8N3J2 | |
| QRLPLLPELQPQPLL | 196 | Q8TE04 | |
| MVPLQLPPPLQPQLI | 1476 | Q13017 | |
| EPPLNLPQPNKLQLI | 1836 | P35498 | |
| LPPQLALQLPQMDAL | 2046 | Q86UP3 | |
| PELLLMPSNQPVNQP | 951 | P18206 | |
| KPLQMPQAPLQPLAQ | 776 | Q9Y3S1 | |
| PLLPALPSLQQNLPM | 831 | O75113 |